ASIA-PACIFIC NEWBORN SCREENING MARKET 2019-2027

Lifesciences | Medical Devices & Consumables

ASIA-PACIFIC NEWBORN SCREENING MARKET 2019-2027

Market By Product, Test Type, Technology And Geography | Forecast 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton Market Research estimates the Asia-Pacific newborn screening market to show an upward trend in terms of revenue and expand with a CAGR of 14.38% in the forecasting period of 2019-2027.

The countries that have been studied in the Asia-Pacific newborn screening market are:

•           China

•           Japan

•           India

•           South Korea

•           ASEAN Countries

•           Australia & New Zealand

•           Rest of Asia-Pacific

Report scope can be customized per your requirements. Request For Customization

The rise of the newborn screening market in China is backed by government programs supporting newborn screening, owing to the increasing instances of congenital disabilities among newborns in the country. According to the ‘China Disabled Persons’ Federation’, approximately 900,000 babies in China are born with birth defects every year. The increase in birth defects such as critical congenital heart defect (CCHD), sickle cell diseases and hearing loss has led to the increase in demand for newborn screening, as these procedures aid in the determination of treatment of these defects at early stages to prevent deaths, intellectual disability and other disabilities. In addition, China has also abolished its ‘one-child policy’, which is expected to increase the number of births in the country.

India is one of the most populated countries with a high annual birth rate. The growth of the newborn screening market in India is primarily driven by the high annual birth rate and the increasing prevalence of birth defects among newborns in the country. According to the World Bank, the crude birth rate in India was 19 babies per 1000 people. Furthermore, the prevalence of birth defects is also increasing in India. According to the National Health Portal (NHP), the prevalence of birth defects in India is 6-7% each year, that translates to approximately 1.7 million birth defects. The common birth defects include congenital deafness, congenital heart disease and neural tube defects. Newborn screening can be used for early identification of these defects. Early identification may help in treatment, that may prevent deaths and other disabilities in newborns. Thus, the demand for newborn screening is expected to increase in India.

 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. ASIA-PACIFIC NEWBORN SCREENING MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. KEY INSIGHTS

2.2.1. DEMAND FOR NEWBORN SCREENING INSTRUMENTS IS RISING STEADILY

2.2.2. GROWTH IN DRY BLOOD SPOT TEST

2.2.3. TECHNIQUES USED IN NEWBORN SCREENING TESTS

2.3. EVOLUTION & TRANSITION OF NEWBORN SCREENING

2.4. PORTER’S FIVE FORCE ANALYSIS

2.4.1. THREAT OF NEW ENTRANTS

2.4.2. THREAT OF SUBSTITUTE

2.4.3. BARGAINING POWER OF SUPPLIERS

2.4.4. BARGAINING POWER OF BUYERS

2.4.5. THREAT OF COMPETITIVE RIVALRY

2.5. KEY IMPACT ANALYSIS

2.5.1. RELIABILITY

2.5.2. COST

2.5.3. AVAILABILITY

2.5.4. TECHNOLOGICAL ADVANCEMENT

2.6. MARKET ATTRACTIVENESS INDEX

2.7. VENDOR SCORECARD

2.8. INDUSTRY COMPONENTS

2.8.1. RAW MATERIAL SUPPLIERS

2.8.2. MANUFACTURERS

2.8.3. DISTRIBUTORS

2.8.4. END-USERS

2.9. REGULATORY FRAMEWORK

2.10. INDUSTRY PLAYER POSITIONING

2.11. KEY MARKET STRATEGIES

2.11.1. PRODUCT LAUNCH

2.12. MARKET DRIVERS

2.12.1. INCREASE IN OCCURRENCES OF NEWBORN DISEASES

2.12.2. GROWING NUMBER OF INFANTS WITH BIRTH DEFECT

2.12.3. BACKING OF GOVERNMENT TOWARDS NEWBORN CHILD HEALTH

2.12.4. RISING AWARENESS FOR PEDIATRIC CONGENITAL HEART DISEASE

2.13. MARKET RESTRAINTS

2.13.1. ABSENCE OF PROPER HEALTHCARE INFRASTRUCTURE FOR NEWBORN BABIES IN DEVELOPING COUNTRIES

2.13.2. SOCIO-ECONOMIC HURDLES IN THE IMPLEMENTATION OF NEWBORN CHILD SCREENING

2.14. MARKET OPPORTUNITIES

2.14.1. NEWBORN SCREENING HELPS IN EARLY IDENTIFICATION AND MANAGEMENT OF AFFECTED NEWBORNS

2.14.2. TECHNOLOGICAL ADVANCEMENTS IN NEWBORN SCREENING

2.14.3. INCREASE IN NUMBER OF PREGNANT WOMEN WITH ADVANCED MATERNAL AGE

2.15. MARKET CHALLENGES

2.15.1. DEARTH OF SKILLED PROFESSIONAL IN HEALTHCARE INDUSTRY

2.15.2. MAINTENANCE OF EQUIPMENT IN HOSPITAL

3. NEWBORN SCREENING MARKET OUTLOOK - BY PRODUCT

3.1. NEWBORN SCREENING INSTRUMENTS

3.2. NEWBORN SCREENING REAGENTS & ASSAY KITS

4. NEWBORN SCREENING MARKET OUTLOOK - BY TEST TYPE

4.1. HEARING SCREEN TEST

4.2. CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST

4.3. DRY BLOOD SPOT TEST

5. NEWBORN SCREENING MARKET OUTLOOK - BY TECHNOLOGY

5.1. TANDEM MASS SPECTROMETRY

5.2. PULSE OXIMETRY

5.3. ENZYME-BASED ASSAYS

5.4. DNA-BASED ASSAYS

5.5. ELECTROPHORESIS

5.6. OTHERS

6. NEWBORN SCREENING MARKET - REGIONAL OUTLOOK

6.1. CHINA

6.2. JAPAN

6.3. INDIA

6.4. SOUTH KOREA

6.5. ASEAN COUNTRIES

6.6. AUSTRALIA & NEW ZEALAND

6.7. REST OF ASIA-PACIFIC

7. COMPETITIVE LANDSCAPE

7.1. SCIEX

7.2. BIOTEK INSTRUMENTS, INC.

7.3. BIO-RAD LABORATORIES, INC.

7.4. CARDINAL HEALTH, INC.

7.5. GE HEALTHCARE, LIMITED

7.6. AGILENT TECHNOLOGIES, INC.

7.7. MASIMO CORPORATION

7.8. NATUS MEDICAL, INCORPORATED

7.9. MEDTRONIC PLC

7.10. THERMO FISHER SCIENTIFIC, INC.

7.11. NEOGEN LABS PVT. LTD.

7.12. PERKINELMER, INC.

7.13. ZENTECH S.A.

7.14. WATERS CORPORATION

7.15. TRIVITRON HEALTHCARE

8. METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of table

TABLE 1: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

TABLE 2: MARKET ATTRACTIVENESS INDEX

TABLE 3: VENDOR SCORECARD

TABLE 4: REGULATORY FRAMEWORK

TABLE 5: LIST OF PRODUCT LAUNCHES

TABLE 6: INFANT MORTALITY RATE IN DEVELOPING COUNTRIES (TOTAL DEATHS/ 1000 LIVE BIRTHS)

TABLE 7: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)

TABLE 8: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027 (IN $ MILLION)

TABLE 9: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027 (IN $ MILLION)

TABLE 10: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

List of Figures

FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

FIGURE 2: KEY BUYING IMPACT ANALYSIS

FIGURE 3: INDUSTRY COMPONENTS

FIGURE 4: INDUSTRY PLAYER POSITIONING IN 2018 (IN %)

FIGURE 5: FERTILITY RATE (AVERAGE BIRTHS PER WOMAN IN %) IN 2017

FIGURE 6: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY NEWBORN SCREENING INSTRUMENTS, 2019-2027 (IN $ MILLION)

FIGURE 7: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY NEWBORN SCREENING REAGENTS & ASSAY KITS, 2019-2027 (IN $ MILLION)

FIGURE 8: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY HEARING SCREEN TEST, 2019-2027 (IN $ MILLION)

FIGURE 9: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST, 2019-2027 (IN $ MILLION)

FIGURE 10: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY DRY BLOOD SPOT TEST, 2019-2027 (IN $ MILLION)

FIGURE 11: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TANDEM MASS SPECTROMETRY, 2019-2027 (IN $ MILLION)

FIGURE 12: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY PULSE OXIMETRY, 2019-2027 (IN $ MILLION)

FIGURE 13: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY ENZYME-BASED ASSAY, 2019-2027 (IN $ MILLION)

FIGURE 14: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY DNA-BASED ASSAYS, 2019-2027 (IN $ MILLION)

FIGURE 15: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY ELECTROPHORESIS, 2019-2027 (IN $ MILLION)

FIGURE 16: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY OTHERS, 2019-2027 (IN $ MILLION)

FIGURE 17: ASIA-PACIFIC NEWBORN SCREENING MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)

FIGURE 18: CHINA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 19: JAPAN NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 20: INDIA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 21: SOUTH KOREA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 22: ASEAN COUNTRIES NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 23: AUSTRALIA & NEW ZEALAND NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 24: REST OF ASIA-PACIFIC NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;